10 research outputs found
Hepatocellular Carcinoma: Known and Emerging Risk Factors
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer
with a high mortality rate. While chronic hepatitis B virus (HBV) and hepatitis
C virus (HCV) infections represent the leading risk factors worldwide, the
spreading of metabolic disorders, such as diabetes, obesity and non-alcoholic
fatty liver disease (NAFLD) justifies the increasing attention on their oncogenic
mechanisms. This review discusses about the main pathogenic mechanisms
implicated in occurrence of HCC in presence of viral and metabolic
diseases. Additionally, it points to the importance of clinical surveillance for
those patients considered at risk of HCC and highlights the strategical role of
serum markers, such as alfa-fetoprotein (αFP) and Protein Induced by Vitamin
K Absence or Antagonist II (PIVKA-II), which, in association to a strictly
instrumental follow-up, contribute to the early detection of hepatic nodules
with a better prognosis for affected patients
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs
Introduction and objectives: Despite chronic hepatitis C (CHC) is still a global burden as the high morbidity and mortality, the recently approved direct-acting antivirals (DAAs) permit a very high rate of sustained virologic response (SVR) in these patients. The clinical improvement due to viral eradication is being documented, however it is not clear why a subset of patients does not benefit in terms of fibrosis regression or hepatocellular carcinoma (HCC) development. Aim of the study was to assess the hepatic stiffness regression at SVR24 and detect factors impacting stiffness course.
Patients and methods: Hepatic stiffness assessed by acoustic radiation force impulse (ARFI) and anthropometric- and biochemical parameters were retrospectively collected by 166 CHC patients treated with DAAs, form baseline and SVR24.
Results: Viral eradication significantly improved overall hepatic stiffness and other related hepatitis hallmarks such as ALT, AST, ÎłGT, platelets count, AST to Platelets ratio Index (APRI), total- and LDL cholesterol. The multiple regression analysis showed that patients with baseline glucose > 110mg/dl presented a stiffness regression significantly lower when compared to low glucose patients (<110mg/dl), moreover baseline HbA1c strongly correlated with DeltaStiffness. 7 patients (4.2%) developed HCC and importantly, presented hyperglycaemia and no stiffness regression nor platelets count recover.
Conclusions: Although viral eradication with DAAs entails overall benefits, glycaemic decompensation negatively affects fibrosis regression and probably facilitates HCC development
Urogenital myiasis caused by Lucilia sericata (Diptera: Calliphoridae) in a domestic rabbit in Italy
The report describes a case of urogenital myiasis in a domestic rabbit Oryctolagus cuniculus L. (Lagomorpha: Leporidae) caused by Lucilia sericata (Meigen; Diptera: Calliphoridae) in region Emilia-Romagna (Northern Italy). The case, occurring in June 2018, is the first one involving L. sericata as an agent of myiasis in a domestic rabbit in Italy. Species identification was based on morphological investigations of males through identification keys. The rabbit developed the urogenital myiasis as a consequence of chronic enteritis causing an accumulation of faeces in the perianal and perineal region
Implementing a cartographic repository of the postglacial Antarctic paleo-shorelines
An improved understanding of the chronology of Antarctic ice sheet deglaciation since the Last Glacial
Maximum-LGM represents a fundamental tool to better define the origin of past and future meltwater influx in
the global oceans (Whitehouse et al., 2012).
Relict shorelines and other evidence of past Relative Sea Level (RSL) evolution were widely used to
understand past ice sheet history and to improve predictions of climate-sea level relationship evolution (Khan
et al., 2015). In the last decades, RSL data in the Antarctic region have been mostly produced using raised
marine features such as beach and marine deposits, marine terraces and isolation basins. The chronology of
these paleo sea-level stands has been established through geomorphological and stratigraphic techniques (John
& Sugden, 1971; Fretwell at al., 2010) and supported by radiometric dating from samples found in beach
deposits and marine/freshwater sediments (Simms et al., 2011; Watcham et al., 2011).
Here we present a new cartographic approach, currently carried out along the Antarctic Peninsula and South
Shetland Islands, which has a twofold aim: (i) the creation of an open access dataset including information
about paleo-shorelines by using a uniform collecting pattern, and (ii) the production of a coherent database
which can be used for improved spatial analyses useful to define the Antarctic shoreline evolution as well as
better constrain the chronology of the deglacial history. As demonstrated by other free data-repositories (https://
www.bgs.ac.uk/geological-data/national-geological-repository/) and similar examples (https://warmcoasts.eu/
world-atlas.html), the new cartographic instrument, built in web-GIS format, will represent a very important
tool for Antarctic coast investigations and a tool for better focusing future researches
Ultra fast-track minimally invasive aortic valve replacement: going beyond reduced incisions
Aortic valve replacement (AVR) via a median sternotomy approach has been largely reported to be safe and long-term efficacious, and currently represents the 'gold standard' approach for aortic stenosis treatment. However, aortic valve surgery has undergone continuous development over the last years, involving less invasive techniques and new technologies to reduce the traumatic impact of the intervention and extend the operability toward increasingly high-risk patients. Indeed, minimally invasive AVR and transcatheter aortic valve replacement caseload have steadily increased leading to a paradigm shift in the treatment of aortic valve disease. In this setting, we have established a multidisciplinary minimally invasive programme to treat patients who require AVR. Herein, we present our approach including (i) reduced chest incision (through a J ministernotomy), aiming to reduce the traumatic impact of the surgical procedure, to decrease blood loss, postoperative pain and wound complications and to increase patient's satisfaction; (ii) rapid-deployment AVR, to reduce operative times, to facilitate minimally invasive approach and to improve haemodynamic outcomes; (iii) minimal invasive extracorporeal circulation system, to improve end-organ protection, to decrease systemic inflammatory response and to promote fast-track anaesthesia and (iv) ultra fast-track anaesthesia, to decrease the rate of postoperative complications and assure better and earlier recovery
del Nido and Histidine-Tryptophan-Ketoglutarate cardioplegia in minimally invasive mitral valve surgery: A propensity-Match study
Introduction: In the last decade, del Nido cardioplegia has been embedded in adult cardiac surgery involving CABG and aortic valve surgical procedures. We reviewed our early experience with del Nido cardioplegia in the setting of minimally invasive mitral valve surgery. Methods: Data on 120 consecutive patients operated between 03/2021 and 06/2022 were retrieved from our internal database (infective endocarditis and urgent operations were excluded). Patients were divided into two groups according to the use of Histidine-Tryptophan-Ketoglutarate or del Nido cardioplegia. A propensity match analysis was performed using thirteen preoperative and intraoperative variables. Several intraoperative data and early postoperative outcomes were investigated, including cardiac enzymes (Troponin I HS and CK-MB) measured upon arrival in the Intensive Care Unit (ICU), after 12Â hours and everyday thereafter. Results: There was no difference in preoperative characteristics and surgical techniques between both unmatched and matched Histidine-Tryptophan-Ketoglutarate and del Nido populations. Patients in the del Nido group received a lower volume of cardioplegia (p < 0.001) and ultrafiltration during CPB (p < 0.001). Histidine-Tryptophan-Ketoglutarate was associated with a lower rate of post cross-clamp spontaneous defibrillation (p < 0.001) and showed a lower level of blood sodium after CPB (p < 0.001). The release of cardiac enzymes was similar between the two groups (p = 0.72). There was no difference in terms of postoperative morbidity and 30Â day mortality. Conclusions: del Nido cardioplegia in the setting of minimally invasive mitral valve surgery seemed safe with acceptable myocardial protection and excellent early outcomes
Improved Early Outcomes in Women Undergoing Aortic Valve Interventions
Surgical aortic valve replacement (SAVR) in female patients has been associated with higher mortality (up to 3.3-8.9%) and postoperative complication rates when compared with their male counterparts. In recent years, TAVI has been shown to provide a greater benefit than SAVR in women. We sought to assess the early outcomes of the contemporary aortic valve intervention practice (surgical and transcatheter) in patients referred to our cardiac surgery unit. The data of consecutive patients who underwent isolated aortic valve intervention for aortic valve stenosis during the 2018-2022 period were retrieved from our internal database. Several preoperative, intraoperative, and postoperative variables were analyzed, including the predicted risk of a prosthesis-patient mismatch. Nine hundred and fifty-five consecutive patients-514 women and 441 men-were included. Among them, 480 patients-276 female and 204 male-received a transcatheter procedure, and 475-238 women and 237 men-had conventional SAVR. The women were older and had higher EuroSCORE II, while the male patients presented a higher incidence of cardiovascular comorbidities. There was no difference in mortality or major postoperative complication rates after either the surgical or transcatheter procedures between the female and male populations. The availability and targeted use of different techniques and technologies have enabled the safe and effective treatment of female patients treated for severe symptomatic aortic valve stenosis with similar results when compared with their male counterparts